Hereditary Cancer Testing Global Market Report 2025

Global Hereditary Cancer Testing Market Report 2024

Hereditary Cancer Testing Global Market Report 2025 – By Test Type( Multi Panel Test, Single-site Genetic Test), By Indication( Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications), By End user( Hospital, Clinics, Diagnostic Centers) – Market Size, Trends, And Global Forecast 2025-2034

Name: Hereditary Cancer Testing Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Hereditary Cancer Testing Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Hereditary Cancer Testing Global Market Report 2025

Proud Members Of

Hereditary Cancer Testing Market Definition

The hereditary cancer testing refers to testing methods for hereditary cancers that can identify specific hereditary cancer diseases and disease-related gene mutations. This testing may decrease the risk of developing particular cancer mutants, allowing for a more comprehensive cancer risk for patients. The primary purpose of this cancer testing is to detect hereditary cancer early and maximize patient health outcomes. This testing procedure assists in identifying cancers for which one has a genetic risk and allows them to receive preventive treatment.

The main types of tests for hereditary cancer are multi panel tests and single-site genetic tests. The multi-panel test refers to a hereditary cancer test that is used to detect many chemicals simultaneously. Panels come in a variety of types, from three-panel tests that look for three substances to five, seven, and 12-panel tests. The choice of conducting the required number of tests is up to the tester’s discretion. Hereditary cancer testing is conducted to detect breast cancer, ovarian cancer, colorectal cancer, and other indications that are used in hospitals, clinics, and diagnostic centers.

Hereditary Cancer Testing Market Segmentation

The hereditary cancer testing market covered in this report is segmented –

1) By Test Type: Multi Panel Test, Single-Site Genetic Test

2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications

3) By End user: Hospital, Clinics, Diagnostic Centers

Subsegments:

1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels

2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation Testing

Hereditary Cancer Testing Market Size and growth rate 2025 to 2029: Graph

Hereditary Cancer Testing Market Size 2025 And Growth Rate

The hereditary cancer testing market size has grown rapidly in recent years. It will grow from $4.32 billion in 2024 to $4.78 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to rising incidence of hereditary cancers, genetic counseling programs, government initiatives for cancer prevention, improved insurance coverage, understanding of gene-environment interactions, patient advocacy and support groups.

Hereditary Cancer Testing Market Growth Forecast

The hereditary cancer testing market size is expected to see rapid growth in the next few years. It will grow to $7.37 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to expansion of targeted therapies, advancements in precision medicine, rise in direct-to-consumer testing, global health initiatives, advancements in bioinformatics. Major trends in the forecast period include advancements in genetic sequencing technologies, telemedicine and remote genetic counseling, precision medicine and personalized treatment, cancer risk assessment models, ethical and legal considerations.

Book your 30 minutes free consultation with our research experts

Hereditary Cancer Testing Market Driver: Unraveling Hereditary Cancer With The Rising Demand For Hereditary Cancer Testing

The increasing prevalence of hereditary cancer is expected to drive the hereditary cancer testing market. Mutations in specific genes passed down from parents to children cause hereditary cancer syndromes. Hereditary cancer testing can detect specific, heritable, disease-related gene mutations, allowing for a comprehensive cancer risk assessment for patients. For instance, in June 2022, according to an article published on BioMed Central about hereditary cancer in clinical practice, about 10% of pancreatic cancer cases have a genetic background. Therefore, the increasing prevalence of hereditary cancer drives the growth of the hereditary cancer testing market.

Hereditary Cancer Testing Market Driver: Hereditary Cancer Testing's Crucial Role Amidst The Escalating Overall Cancer Burden

An increase in the overall cancer burden is expected to propel the hereditary cancer testing market going forward. Cancer is a group of diseases characterized by the uncontrolled and abnormal growth of cells, which can invade and spread to other tissues and parts of the body. In a healthy organism, cells follow a regulated process of growth, division, and death. Hereditary cancer testing plays a critical role in addressing the overall burden of cancer by identifying individuals with a genetic predisposition to certain cancers. By assessing inherited mutations and familial risk factors, this testing helps identify individuals at higher risk, enabling early intervention, personalized treatment plans, and proactive preventive measures. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia the number of cancer cases diagnosed increased from 160,570 in 2022 to 164,694 in 2023, reflecting a notable rise over the year. This upward trend highlights the growing prevalence of cancer within the country. Therefore, an increase in the overall cancer burden is driving the hereditary cancer testing market.

Global Hereditary Cancer Testing Market Major Players

Major companies operating in the hereditary cancer testing market are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.

Global Hereditary Cancer Testing Market Trend: Myriad Genetics' Cutting-Edge Approach In Hereditary Cancer Testing Technology

Technological innovation is a key trend gaining popularity in the hereditary cancer testing market. Key players in the market are focusing on technological innovations to sustain their market positions. For instance, in March 2022, Myriad Genetics, a US-based genetic testing and precision medicine company, launched genetic testing with a Polygenic Breast Cancer Risk Assessment Score for all ancestries. This MyRisk Hereditary Cancer test with RiskScore offers a personalized breast cancer risk assessment to all women who have never been diagnosed with breast cancer, regardless of ancestry.

Global Hereditary Cancer Testing Market Trend: Enhancing Patient Care Through Molecular Diagnostics

Major companies operating in the hereditary cancer testing market are focusing on innovative technologies, such as molecular diagnostic tumor testing, to enhance accuracy, improve patient outcomes, and personalize treatment strategies. Molecular diagnostic tumor testing involves analyzing a tumor's genetic and molecular characteristics to inform treatment decisions and predict outcomes. For instance, in February 2023, Chubb Business Services India Private Limited, an India-based global insurance company, launched Cancer Advocate Plus. The program includes genetics-based testing to identify inherited genes that increase cancer risk. This proactive approach allows individuals to understand their susceptibility to various cancers, facilitating early intervention and personalized care strategies.

Hereditary Cancer Testing Market Merger And Acquisition: Exact Sciences' Strategic Acquisition Of Preventiongenetics For Comprehensive Genetic Testing Portfolio

In January 2022, Exact Sciences, a US-based molecular diagnostics company, acquired PreventionGenetics for approximately $190 million. This acquisition provides Exact Sciences' advanced cancer tests portfolio with PreventionGenetics' comprehensive genetic testing portfolio which is complementary in nature. PreventionGenetics will also provide the clinical lab, expertise, and foundational technology necessary to accelerate the availability of HCT and help more patients know their germline risk of cancer and other diseases. PreventionGenetics is a US-based genetic testing And DNA testing laboratory.

Regional Outlook For The Global Hereditary Cancer Testing Market

North America was the largest region in the hereditary cancer testing market in 2024. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hereditary cancer testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hereditary Cancer Testing Market?

The hereditary cancer testing market includes revenues earned by entities by providing hereditary cancer testing for lung cancer, cervical cancer, prostate cancer, stomach/gastric cancer, melanoma, sarcoma, and uterine cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Hereditary Cancer Testing Industry?

The hereditary cancer testing market research report is one of a series of new reports from The Business Research Company that provides hereditary cancer testing market statistics, including hereditary cancer testing industry global market size, regional shares, competitors with a hereditary cancer testing market share, detailed hereditary cancer testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary cancer testing industry. This hereditary cancer testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hereditary Cancer Testing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.78 billion
Revenue Forecast In 2034	$7.37 billion
Growth Rate	CAGR of 11.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Test Type: Multi Panel Test, Single-Site Genetic Test 2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications 3) By End user: Hospital, Clinics, Diagnostic Centers Subsegments: 1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels 2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation Testing
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Hereditary Cancer Testing Market Characteristics

3. Hereditary Cancer Testing Market Trends And Strategies

4. Hereditary Cancer Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hereditary Cancer Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Hereditary Cancer Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Hereditary Cancer Testing Market Growth Rate Analysis

5.4. Global Hereditary Cancer Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Hereditary Cancer Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Hereditary Cancer Testing Total Addressable Market (TAM)

6. Hereditary Cancer Testing Market Segmentation

6.1. Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Multi Panel Test

Single-site Genetic Test

6.2. Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Ovarian Cancer

Colorectal Cancer

Other Indications

6.3. Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Clinics

Diagnostic Centers

6.4. Global Hereditary Cancer Testing Market, Sub-Segmentation Of Multi Panel Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Comprehensive Genetic Panels

Targeted Gene Panels

6.5. Global Hereditary Cancer Testing Market, Sub-Segmentation Of Single-Site Genetic Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Specific Gene Testing

Familial Mutation Testing

7. Hereditary Cancer Testing Market Regional And Country Analysis

7.1. Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hereditary Cancer Testing Market

8.1. Asia-Pacific Hereditary Cancer Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hereditary Cancer Testing Market

9.1. China Hereditary Cancer Testing Market Overview

9.2. China Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hereditary Cancer Testing Market

10.1. India Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hereditary Cancer Testing Market

11.1. Japan Hereditary Cancer Testing Market Overview

11.2. Japan Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hereditary Cancer Testing Market

12.1. Australia Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hereditary Cancer Testing Market

13.1. Indonesia Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hereditary Cancer Testing Market

14.1. South Korea Hereditary Cancer Testing Market Overview

14.2. South Korea Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hereditary Cancer Testing Market

15.1. Western Europe Hereditary Cancer Testing Market Overview

15.2. Western Europe Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hereditary Cancer Testing Market

16.1. UK Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hereditary Cancer Testing Market

17.1. Germany Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hereditary Cancer Testing Market

18.1. France Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hereditary Cancer Testing Market

19.1. Italy Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hereditary Cancer Testing Market

20.1. Spain Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hereditary Cancer Testing Market

21.1. Eastern Europe Hereditary Cancer Testing Market Overview

21.2. Eastern Europe Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hereditary Cancer Testing Market

22.1. Russia Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hereditary Cancer Testing Market

23.1. North America Hereditary Cancer Testing Market Overview

23.2. North America Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hereditary Cancer Testing Market

24.1. USA Hereditary Cancer Testing Market Overview

24.2. USA Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hereditary Cancer Testing Market

25.1. Canada Hereditary Cancer Testing Market Overview

25.2. Canada Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hereditary Cancer Testing Market

26.1. South America Hereditary Cancer Testing Market Overview

26.2. South America Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hereditary Cancer Testing Market

27.1. Brazil Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hereditary Cancer Testing Market

28.1. Middle East Hereditary Cancer Testing Market Overview

28.2. Middle East Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hereditary Cancer Testing Market

29.1. Africa Hereditary Cancer Testing Market Overview

29.2. Africa Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hereditary Cancer Testing Market Competitive Landscape And Company Profiles

30.1. Hereditary Cancer Testing Market Competitive Landscape

30.2. Hereditary Cancer Testing Market Company Profiles

30.2.1. Centogene NV Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Ambry Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Myriad Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. NeoGenomics Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

31. Hereditary Cancer Testing Market Other Major And Innovative Companies

31.1. PreventionGenetics

31.2. Fulgent Genetics Inc.

31.3. Invitae Corporation

31.4. Medical Diagnostic Laboratories LLC

31.5. Natera Inc.

31.6. Color Health Inc.

31.7. CooperSurgical Inc.

31.8. OPKO Health Inc.

31.9. Illumina Inc.

31.10. Laboratory Corporation of America Holdings

31.11. Pathway Genomics Corporation

31.12. Strand Life Sciences Private Limited

31.13. Progenity Inc.

31.14. Myogenes Ltd.

31.15. Associated Regional and University Pathologists Inc.

32. Global Hereditary Cancer Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hereditary Cancer Testing Market

34. Recent Developments In The Hereditary Cancer Testing Market

35. Hereditary Cancer Testing Market High Potential Countries, Segments and Strategies

35.1 Hereditary Cancer Testing Market In 2029 - Countries Offering Most New Opportunities

35.2 Hereditary Cancer Testing Market In 2029 - Segments Offering Most New Opportunities

35.3 Hereditary Cancer Testing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Hereditary Cancer Testing Market, Sub-Segmentation Of Multi Panel Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Hereditary Cancer Testing Market, Sub-Segmentation Of Single-Site Genetic Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Centogene NV Financial Performance

Table 77: Ambry Genetics Inc. Financial Performance

Table 78: Myriad Genetics Inc. Financial Performance

Table 79: NeoGenomics Laboratories Inc. Financial Performance

Table 80: Quest Diagnostics Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Hereditary Cancer Testing Market, Sub-Segmentation Of Multi Panel Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Hereditary Cancer Testing Market, Sub-Segmentation Of Single-Site Genetic Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Centogene NV Financial Performance

Figure 77: Ambry Genetics Inc. Financial Performance

Figure 78: Myriad Genetics Inc. Financial Performance

Figure 79: NeoGenomics Laboratories Inc. Financial Performance

Figure 80: Quest Diagnostics Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Healthcare Analytical Testing Services Global Market Report 2025 – By Type (Bioanalytical Testing Services, Physical Characterization Services, Method Development And Validation Testing Services, Raw Material Testing Services, Batch-Release Testing Services, Stability Testing, Microbial Testing Services, Other Types), By End User (Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Contract Research Organizations) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Automotive Testing, Inspection and Certification Global Market Report 2025 – By Service Type (Testing Services, Inspection Services, Certification Services, Other Services), By Sourcing Type (In-house, Outsourced), By Application (Electrical Systems and Components, Telematics, Interior and Exterior Materials and Components, Fluids and Lubricants, Vehicle Inspection Services, Homologation Testing, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cold Plasma Global Market Report 2025 – By Regime (Atmospheric Cold Plasma, Low-Pressure Cold Plasma ), By Technology (Remote Treatment, Direct Treatment, Electrode Contact ), By Application (Wound Healing, Blood Coagulation, Dentistry, Cancer Treatment, Other Medical Applications), By End Use Sector (Automotive, Electronics & Semiconductors, Food Processing & Packaging, Medical, Aerospace, Polymers & Plastics, Other End-User Sector) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Testing, Inspection, And Certification Global Market Report 2025 – By Service Type (Testing Service, Inspection Service, Certification Service), By Sourcing Type (In-House, Outsourced), By Application (Quality And Safety, Production Evaluation, Industrial Inspection, System Certification), By End-User (Consumer Goods And Retail, Food And Agriculture, Oil And Gas, Construction And Engineering, Energy And Chemicals, Manufacturing, Transportation, Industrial And Automotive, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Services Global Market Report 2025 – By Type (Civic Services, Real Estate, Leasing, Commercial Services, Personal Services, Repair and Maintenance), By Component (Hardware, Software, Service), By Mode (Online, Offline) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Analytical Laboratory Instrument Global Market Report 2025 – By Type (Element Analysis, Separation Analysis, Molecular Analysis, Other Types), By Application (Research, Clinical, Diagnostic, Other Applications), By End-User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Biotechnology, Other End-users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Analytical Standards Global Market Report 2025 – By Type (Organic Standards, Inorganic Standards), By Technique (Chromatography, Spectroscopy, Titrimetry, Physical Property Testing), By Application (Bioanalytical Testing, Stability Testing, Raw Material Testing, Dissolution Testing, Microbiology Testing, Physical Properties Testing, Toxicity Testing, Contamination Testing, QA/QC Testing, Proficiency Testing, Other Applications.), By End User (Food And Beverages Standards, Forensic Standards, Veterinary Drug Standards, Petrochemistry Standards, Environmental, Pharmaceutical And Life Science Standards, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2025 – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By End User (Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the hereditary cancer testing market?

How will the hereditary cancer testing market drivers and restraints affect the hereditary cancer testing market dynamics? What forces will shape the hereditary cancer testing industry going forward?

The hereditary cancer testing market major growth driver - The hereditary cancer testing refers to testing methods for hereditary cancers that can identify specific hereditary cancer diseases and disease-related gene mutations. This testing may decrease the risk of developing particular cancer mutants, allowing for a more comprehensive cancer risk for patients. The primary purpose of this cancer testing is to detect hereditary cancer early and maximize patient health outcomes. This testing procedure assists in identifying cancers for which one has a genetic risk and allows them to receive preventive treatment.. For further insights on the hereditary cancer testing market, request a sample here

What is the forecast market size or the forecast market value of the hereditary cancer testing market?

The hereditary cancer testing market size has grown rapidly in recent years. It will grow from $4.32 billion in 2024 to $4.78 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to rising incidence of hereditary cancers, genetic counseling programs, government initiatives for cancer prevention, improved insurance coverage, understanding of gene-environment interactions, patient advocacy and support groups. The hereditary cancer testing market size is expected to see rapid growth in the next few years. It will grow to $7.37 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to expansion of targeted therapies, advancements in precision medicine, rise in direct-to-consumer testing, global health initiatives, advancements in bioinformatics. Major trends in the forecast period include advancements in genetic sequencing technologies, telemedicine and remote genetic counseling, precision medicine and personalized treatment, cancer risk assessment models, ethical and legal considerations. For further insights on the hereditary cancer testing market, request a sample here

How is the hereditary cancer testing market segmented?

The hereditary cancer testing market is segmented
1) By Test Type: Multi Panel Test, Single-Site Genetic Test
2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications
3) By End user: Hospital, Clinics, Diagnostic Centers Subsegments:
1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels
2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation TestingFor further insights on the hereditary cancer testing market, request a sample here

Which region has the largest share of the hereditary cancer testing market? What are the other regions covered in the report?

North America was the largest region in the hereditary cancer testing market in 2024. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the hereditary cancer testing market, request a sample here.

Who are the major players in the hereditary cancer testing market?

What are the key trends in the hereditary cancer testing market?

Major trend in the hereditary cancer testing market - Myriad Genetics' Cutting-Edge Approach In Hereditary Cancer Testing Technology. For further insights on the hereditary cancer testing market, request a sample here.

What are the major opportunities in the hereditary cancer testing market? What are the strategies for the hereditary cancer testing market?

For detailed insights on the major opportunities and strategies in the hereditary cancer testing market, request a sample here.

How does the hereditary cancer testing market relate to the overall economy and other similar markets?

For detailed insights on hereditary cancer testing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the hereditary cancer testing industry?

For detailed insights on the mergers and acquisitions in the hereditary cancer testing industry, request a sample here.

What are the key dynamics influencing the hereditary cancer testing market growth? SWOT analysis of the hereditary cancer testing market.

For detailed insights on the key dynamics influencing the hereditary cancer testing market growth and SWOT analysis of the hereditary cancer testing industry, request a sample here.